Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Spectra7 Announces Private PlacementPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Spectra7 Announces Private Placement


(TSXV:SEV) Spectra7 Microsystems Inc. (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announces that it

Acadia Healthcare Announces Definitive Agreement to Sell U.K. OperationsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Acadia Healthcare Announces Definitive Agreement to Sell U.K. Operations


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced that it has entered into a definitive agreement to sell its U.K. operations to Waterland Private Equity

Columbia Care Opens its First Dispensary in Virginia
Columbia Care Opens its First Dispensary in Virginia


Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) has announced today the opening of its first dispensary in Virginia as the only vertically

Discover Financial Services Announces Fourth Quarter 2020 Earnings Release on January 20, 2021 and Conference Call on January 21, 2021Photo, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Discover Financial Services Announces Fourth Quarter 2020 Earnings Release on January 20, 2021 and Conference Call on January 21, 2021


Discover Financial Services (NYSE: DFS) plans to report its fourth quarter 2020 results after the market closes on Wednesday, January 20, 2021. The earnings release will be available through

Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021Photo, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021


Customers Bancorp (NYSE:CUBI) was recently identified as one of the “best financial stocks to buy” in 2021 by Kiplinger. The publication looked at the financial sector, one of the hardest-hit

Connection (CNXN) Announces a Special Dividend to ShareholdersPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.theapi.app/temp/bee95973-d201-429b-849e-52867059bd1a.png
Connection (CNXN) Announces a Special Dividend to Shareholders


Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, and education markets, today announced that its Board of Directors

Koch Real Estate Investments Makes $32 Million Long-Term Investment in Ladder Capital Corp
Koch Real Estate Investments Makes $32 Million Long-Term Investment in Ladder Capital Corp


Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) announced that an affiliate of Koch Real Estate Investments, LLC exercised its option to invest $32 million in Ladder’s common equity

Alcoa Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference CallPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Alcoa Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call


Alcoa Corporation plans to announce its fourth quarter and full year 2020 financial results on Wednesday, January 20, 2021 after the close of trading on the New York Stock Exchange.



The press

NOXXON Announces Initiation of NOX-A12 Manufacturing for Future Clinical StudiesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
NOXXON Announces Initiation of NOX-A12 Manufacturing for Future Clinical Studies


Regulatory News:



NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®Photo, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU)

Ennis Will Acquire Assets of InfosealPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Ennis Will Acquire Assets of Infoseal


Ennis, Inc. (the “Company"), (NYSE: EBF), today announced that one of its wholly owned subsidiaries has entered into a Letter of Intent to acquire the assets and assume some liabilities of Infoseal

Insight Awarded Global SASE Partner of the Year from Palo Alto NetworksPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Insight Awarded Global SASE Partner of the Year from Palo Alto Networks


Insight Enterprises (NASDAQ: NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, was named Palo Alto Networks Global SASE Partner of the Year.

Pitney Bowes Announces Pricing Update for Delivery Services as Parcel Volumes Continue to Surge into 2021Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
Pitney Bowes Announces Pricing Update for Delivery Services as Parcel Volumes Continue to Surge into 2021


Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that pricing

Angelika Anywhere: Curated for Film LoversPhoto, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/bda07ced-e79e-4489-b731-ada601660c8e.png
Angelika Anywhere: Curated for Film Lovers


Reading International, Inc. (NASDAQ: RDI) announces the launch of Angelika Anywhere, a streaming platform curated for film lovers, as inspired by its Angelika Film Center in New York City, North

Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical TrialPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial


Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the company has completed submission of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for

NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBRPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBR


NCR Corporation (NYSE: NCR) leads the global restaurant point-of-sale (POS) software market according to research and consulting firm RBR. The Global POS Software 2020 Report conducted by RBR

Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually Photo, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually


Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company with Phase 3 programs in presbyopia, myopia and mydriasis, today announced that it has submitted a New Drug

Essex Property Trust Announces Executive Leadership Succession
Essex Property Trust Announces Executive Leadership Succession


Essex Property Trust, Inc. (NYSE:ESS) announced today the planned succession for the Chief Operating Officer (COO) and the Chief Financial Officer (CFO).



John Burkart will retire as the Company’s

LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDAPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA


Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for LORBRENA ® (lorlatinib) as

US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021Photo, wide shot, wide-angle lens,  Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png
US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021


US Foods Holding Corp. (NYSE: USFD) Chairman and Chief Executive Officer, Pietro Satriano, and Chief Financial Officer, Dirk Locascio, will present at the ICR Conference on Monday, Jan. 11 at 1:30

Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral MutationsPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations


Eurofins Genomics (Paris:ERF) launches an optimised, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo

Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and WebcastPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/fb3845ac-e3c6-43ef-86c1-b57ed8c272c4.png
Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and Webcast


Polaris Inc. (NYSE: PII) announced today that it will release its fourth quarter and full year 2020 financial results on Tuesday, January 26, 2021, and will hold a conference call and webcast at

Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact AwardPhoto, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact Award


Customers Bank was selected as the winner of the highly coveted 2020 Best Example of Making an Impact on Business Award presented by Everbridge, an organization focused on life-saving efforts

Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering
Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering


Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), today announced it has entered into definitive agreements with investors for the purchase and sale of

Lineage Cell Therapeutics Provides End of Year Shareholder Letter Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Lineage Cell Therapeutics Provides End of Year Shareholder Letter


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided a year-end review